p300 Modulates the BRCA1 inhibition of estrogen receptor activity.
Saijun Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), Eliot M. Rosen(Albert Einstein College of Medicine), Michael R. Erdos(National Institutes of Health), Yong Xian(Albert Einstein College of Medicine), Qinghui Meng, Chenguang Wang(Albert Einstein College of Medicine), Jian Wang(Sun Yat-sen University), Paul Webb(University of California, San Francisco), Itzhak D. Goldberg(Angion (United States)), Peter J. Kushner(Olema Pharmaceuticals (United States)), Renqi Yuan, Richard G. Pestell(Baruch S. Blumberg Institute)
PubMed
January 1, 2002
Cited by 150
Related Papers
A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants
|Science|2007|2.8k
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
|Science|1999|494
In vivo renal clearance, biodistribution, toxicity of gold nanoclusters
|Biomaterials|2012|486
Ultrasmall Au<sub>10−12</sub>(SG)<sub>10−12</sub> Nanomolecules for High Tumor Specificity and Cancer Radiotherapy
|Advanced Materials|2014|438
Enhanced Tumor Accumulation of Sub‐2 nm Gold Nanoclusters for Cancer Radiation Therapy
|Advanced Healthcare Materials|2013|372